Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

    Accelerating diverse, evidence-based cancer interventions via pragmatic trials for improved health equity with UG3/UH3 funding support.

    Browse similar grants
    Cancer Research Grants 2026

    This grant is no longer accepting proposals

    National Institutes of Health has archived this opportunity.

    Funder: National Institutes of Health

    Due Dates: June 14, 2025 (New) | July 14, 2025 (Renewal/Resubmission/Revision) | October 17, 2025 (New) | November 17, 2025 (Renewal/Resubmission/Revision)

    Funding Amounts: Up to $500,000 direct costs/year (UG3, max 2 years); up to $750,000 direct costs/year (UH3, max 4 years); total project period up to 6 years.

    Summary: Supports pragmatic trials to test evidence-based cancer-related interventions across the cancer control continuum, emphasizing health equity and diverse U.S. populations/settings.

    Key Information: UG3/UH3 phased cooperative agreement; clinical trial required; milestones must be met for UH3 transition; non-domestic organizations not eligible.


    Description

    This opportunity from the National Cancer Institute (NCI) aims to accelerate the development and testing of evidence-based cancer-related interventions that address the diversity of people, places, and contexts across the United States. The program specifically supports pragmatic trials—studies designed to evaluate interventions in real-world settings—to improve cancer-related outcomes across the cancer control continuum (prevention, detection, diagnosis, treatment, survivorship, and end-of-life care).

    The funding mechanism is a two-phase UG3/UH3 cooperative agreement:

    • UG3 phase (up to 2 years): Supports preparatory activities, including piloting and refining the intervention, finalizing study protocols, and establishing partnerships.
    • UH3 phase (up to 4 years): Supports the full-scale pragmatic trial, contingent on successful completion of UG3 milestones and NCI approval.

    Interventions may include behavioral, technology-mediated, community-based, healthcare delivery, multilevel, or implementation strategies. Projects are encouraged to focus on populations experiencing health disparities and settings with limited resources.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.